NEW YORK, March 5 (GenomeWeb News) - Ortho-Clinical Diagnostics has ended an exclusive agreement to license certain Alzheimer's diagnostics technology from SynX Pharma, and has stopped trying to develop the technology, SynX said today.
As a result, Toronto-based SynX has re-acquired from Ortho the worldwide rights to the technology, the company said.
SynX won a